Catalent Inc (NYSE:CTLT) Price Declined While Pax World Management Llc Upped Position

May 16, 2018 - By Madeline Delgado

Catalent, Inc. (NYSE:CTLT) Corporate LogoBig Money Sentiment decreased to 1.44 in Q4 2017. It has change of 1.17, from 2017Q3’s 2.61. The ratio dived due to CTLT positioning: 37 sold and 68 reduced. 41 funds bought stakes and 110 increased stakes. Investors holded 130.89 million in 2017Q3 but now own 130.69 million shares or 0.15% less. Cubist Systematic Strategies Limited Com has invested 0.07% in Catalent, Inc. (NYSE:CTLT). Susquehanna Intll Gru Ltd Liability Partnership accumulated 34,857 shs or 0% of the stock. Hsbc Pcl owns 0% invested in Catalent, Inc. (NYSE:CTLT) for 18,062 shs. Hightower Advisors Ltd stated it has 13,848 shs. Prudential Fin holds 0.04% of its capital in Catalent, Inc. (NYSE:CTLT) for 703,740 shs. Stifel Fincl Corporation stated it has 0% in Catalent, Inc. (NYSE:CTLT). Ameriprise Fincl Inc owns 808,265 shs or 0.02% of their US capital. Ajo Lp reported 0.15% stake. Earnest Limited Co holds 2.50M shs. Stratos Wealth Limited owns 142 shs. Globeflex Capital Limited Partnership invested 0.35% in Catalent, Inc. (NYSE:CTLT). Credit Suisse Ag invested in 262,039 shs. Kornitzer Mngmt Ks accumulated 358,250 shs. Schroder Invest Management Group reported 3.71 million shs. Lazard Asset Mngmt Lc has invested 0.02% in Catalent, Inc. (NYSE:CTLT).

CTLT had 2 insider sales and 0 buys since December 11, 2017. This’s net activity of $7.57 million. Chiminski John R had sold 181,458 shs worth $7.19M on Monday, December 11.

The holdings In Catalent Inc (NYSE:CTLT) held by Pax World Management Llc was upped. According to 2018Q1 SEC report the rise is 152.29%. 261,851 shares were bought by Pax World Management Llc as Catalent Inc (NYSE:CTLT) stock declined 4.27% with the market. It held 433,796 shares of Catalent Inc (NYSE:CTLT) at the end of 2018Q1, valued at $17.81 million, up from 171,945 last quarter. $5.25 billion is the MC of Catalent Inc. Ticker’s shares touched $39.38 during the last trading session after 0.33% change.Currently Catalent, Inc. is uptrending after 39.51% change in last May 16, 2017. CTLT has 506,354 shares volume. The stock outperformed the S&P 500 by 27.96%.

Pax World Management Llc cut its stake in Ss&C Technologies Hldgs Inc (NASDAQ:SSNC) and reduced Cisco Sys Inc (NASDAQ:CSCO) position by 418,740 shares for a total of 97,497 shares.

Pax World Management Llc is a New Hampshire-based institutional investor with more than $3.21 billion AUM in July, 2014. Taken from Pax World Management latest Adv, the fund reported to have 46 full and part-time employees. Among which 15 performing investment advisory and research functions. The institutional investor had between 11-25 clients.

Catalent, Inc. (NYSE:CTLT) Ratings Coverage

In total 8 analysts cover Catalent (NYSE:CTLT). “Buy” rating has 5, “Sell” are 0, while 3 are “Hold”. (NYSE:CTLT) has 63% bullish analysts. 9 are the (NYSE:CTLT)’s ratings reports on 16 May 2018 according to StockzIntelligence Inc. On Tuesday, February 6 the company was downgraded by Stephens. On Wednesday, March 28 the stock has “Overweight” rating by KeyBanc Capital Markets. On Monday, February 5 RBC Capital Markets maintained the shares of CTLT in report with “Buy” rating. The stock rating was upgraded by Raymond James to “Outperform” on Wednesday, March 21. In Tuesday, February 6 report Bank of America maintained the stock with “Buy” rating. On Monday, February 5 the firm has “Hold” rating given by Jefferies.

Catalent, Inc. provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products worldwide.The firm is valued at $5.25 billion. It operates through three divisions: Softgel Technologies, Drug Delivery Solutions, and Clinical Supply Services.71.86 is the P/E ratio. The Softgel Technologies segment offers formulation, development, and manufacturing services for softgels, which are used in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, and unit-dose cosmetics.

Catalent, Inc. (NYSE:CTLT) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.